On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Umeå University

InstitutionResearch output, impact & collaborations

Umeå University is a institution indexed in ScholarIQ from OpenAlex.

What is known about Umeå University?

ScholarIQrecord summary

Umeå University is a research organisation in Umeå, SE. OpenAlex records 85,600 works and 7,647,717 citations for it. 11,917 researchers list it as their most recent affiliation.

How many works does Umeå University have?

ScholarIQindexed works

Umeå University has 85,600 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Umeå University have?

ScholarIQcitation count

Umeå University has 7,647,717 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Umeå University?

ScholarIQresearcher count

Umeå University has 11,917 researchers in the ScholarIQ index.

What is the average h-index at Umeå University?

ScholarIQavg h-index

Umeå University has an average h-index of 70.4 in OpenAlex.

What is the ROR of Umeå University?

ScholarIQror

The ROR for Umeå University is on the source record.

What is the OpenAlex record for Umeå University?

ScholarIQopenalex

The OpenAlex for Umeå University is on the source record.

Who are the most-cited researchers behind Umeå University?

ScholarIQtop researchers by citations
1
Lars Nyberg · Functional Brain Connectivity Studies
771 works71,433 citations
2
Svante Wold · Spectroscopy and Chemometric Analyses
451 works56,376 citations
3
Rolf Adolfsson · Genetic Associations and Epidemiology
444 works44,433 citations
4
Stefan Söderberg · Diabetes, Cardiovascular Risks, and Lipoproteins
566 works43,751 citations
5
Göran Hallmans · Genetic Associations and Epidemiology
451 works38,527 citations

What are the most-cited papers on Umeå University?

ScholarIQmost cited works
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel
The Lancet. 20025,421 Citations
Mortality risk attributable to high and low ambient temperature: a multicountry observational study
Antonio Gasparrini, Yuming Guo, Masahiro Hashizume, Éric Lavigne, Antonella Zanobetti, Joel Schwartz, Aurelio Tobı́as, Shilu Tong, Joacim Rocklöv, Bertil Forsberg, Michela Leone, Manuela De Sario, Michelle L. Bell, Yue Leon Guo, Chang‐Fu Wu, Haidong Kan, Seung‐Muk Yi, Micheline de Sousa Zanotti Stagliorio Coêlho, Paulo Hilário Nascimento Saldiva, Yasushi Honda, Ho Kim, Ben Armstrong
The Lancet. 20152,929 CitationsOPEN ACCESS
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
Lennart Hansson, Lars Lindholm, Leo Niskanen, Jan Lanke, Thomas Hedner, Anders Niklason, K Luomanmäki, Björn Dahlöf, Ulf dé Fairé, Claes Mörlin, Bengt E. Karlberg, P-O Wester, Jan-Erik Björck
The Lancet. 19992,015 Citations
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
Björn Dahlöf, L. Hansson, Lars Lindholm, Bengt Scherstén, Tord Ekbom, P-O Wester
The Lancet. 19911,893 Citations
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Lars Lindholm, Hans Ibsen, Björn Dahlöf, Richard B. Devereux, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Stevo Julius, Sverre E. Kjeldsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Peter Aurup, Jonathan M. Edelman, Steven Snapinn
The Lancet. 20021,571 Citations

How much of the research on Umeå University is open access?

ScholarIQopen access share
25%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
8%
Bronze
17%
Closed
75%

Related on ScholarIQ

470M+ articles · 14-day free trial